Shanghai Kaibao Pharmaceutical CO.,Ltd

SZSE:300039 Stock Report

Market Cap: CN¥6.8b

Shanghai Kaibao PharmaceuticalLtd Balance Sheet Health

Financial Health criteria checks 5/6

Shanghai Kaibao PharmaceuticalLtd has a total shareholder equity of CN¥3.9B and total debt of CN¥3.0M, which brings its debt-to-equity ratio to 0.08%. Its total assets and total liabilities are CN¥4.3B and CN¥472.9M respectively. Shanghai Kaibao PharmaceuticalLtd's EBIT is CN¥324.5M making its interest coverage ratio -5.2. It has cash and short-term investments of CN¥1.3B.

Key information

0.08%

Debt to equity ratio

CN¥2.99m

Debt

Interest coverage ratio-5.2x
CashCN¥1.32b
EquityCN¥3.85b
Total liabilitiesCN¥472.89m
Total assetsCN¥4.33b

Recent financial health updates

No updates

Recent updates

A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Jul 31
A Piece Of The Puzzle Missing From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Share Price

Financial Position Analysis

Short Term Liabilities: 300039's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥316.7M).

Long Term Liabilities: 300039's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥156.2M).


Debt to Equity History and Analysis

Debt Level: 300039 has more cash than its total debt.

Reducing Debt: 300039's debt to equity ratio has increased from 0% to 0.08% over the past 5 years.

Debt Coverage: 300039's debt is well covered by operating cash flow (11769.2%).

Interest Coverage: 300039 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies